MK-677 (Ibutamoren): Dosage, Half-Life & Complete Guide

MK-677, also known as Ibutamoren or Ibutamoren Mesylate, is an orally active growth hormone secretagogue. Despite being grouped with peptides, MK-677 is technically a non-peptide ghrelin mimetic — a small molecule that mimics the hunger hormone ghrelin by binding to the ghrelin receptor (GHS-R1a) in the brain and pituitary gland. This triggers the pituitary to release growth hormone.

The key appeal of MK-677 is convenience: it is taken as a pill or capsule once daily, eliminating the need for injections that other GH peptides require. It was developed by Merck and has been studied in clinical trials for growth hormone deficiency, muscle wasting, osteoporosis, and age-related frailty, though it has never received FDA approval.

MK-677 has a half-life of approximately 24 hours, which is substantially longer than any injectable GH peptide. For comparison, Ipamorelin has a half-life of about 2 hours and CJC-1295 (no DAC) lasts roughly 30 minutes.

This 24-hour half-life means a single daily dose provides continuous ghrelin receptor stimulation around the clock. While this is convenient, it also means the effects — including appetite stimulation, water retention, and GH elevation — persist 24/7 with no off-period during the day.

Peak plasma concentration occurs approximately 1 hour after oral administration. MK-677 elevates GH levels in a pulsatile fashion for the first few hours, then maintains a sustained elevation above baseline for the remainder of the 24-hour period. IGF-1 levels increase by 40-60% and remain elevated with continued daily dosing.

Standard dose: 10-25 mg orally once daily, typically taken before bed. The pre-bed timing aligns with the body's natural nocturnal GH surge and means the strongest appetite stimulation occurs while you are asleep.

Conservative / anti-aging: 10 mg daily. This produces meaningful IGF-1 elevation with fewer side effects. Many users find 10 mg provides 80% of the benefits with significantly less appetite increase and water retention.

Standard / body composition: 25 mg daily. The dose used in most clinical trials. Produces the strongest GH and IGF-1 response but also the most pronounced side effects.

Cycling: Most protocols recommend 8-12 weeks on, 4 weeks off. Some users run MK-677 continuously at 10 mg, though insulin sensitivity should be monitored with extended use. Unlike injectable GHRPs, MK-677 does not appear to cause rapid receptor desensitization, so longer cycles are feasible.

MK-677 vs Ipamorelin + CJC-1295: The injectable stack produces cleaner, pulsatile GH release that closely mimics natural secretion patterns. MK-677 provides more sustained, less pulsatile elevation. The injectable stack causes less appetite increase, less water retention, and less impact on insulin sensitivity. However, MK-677 requires no injections, no reconstitution, and no refrigeration.

MK-677 vs HGH: Direct HGH injection provides the most predictable and controllable GH levels. MK-677 stimulates your own GH production, which has the advantage of maintaining natural feedback mechanisms but the disadvantage of less precise dosing. HGH is far more expensive.

MK-677 vs GHRP-6: Both cause significant appetite increase. GHRP-6 has a shorter duration of action (requires 2-3 daily injections) and causes more cortisol elevation. MK-677 is more convenient but the appetite effect lasts all day.

Bottom line: MK-677 is the best choice when injection avoidance is the priority. Injectable peptides are better when clean GH pulsatility and minimal side effects matter more than convenience.

Appetite increase: The most common and sometimes intense side effect. MK-677 activates ghrelin receptors, which directly stimulate hunger. This can be counterproductive for fat loss goals. The effect is strongest in the first 2-4 weeks and may partially diminish with continued use.

Water retention: Bloating and puffiness, particularly in the face and extremities. Usually most noticeable in the first few weeks. Reducing sodium intake and staying hydrated can help.

Reduced insulin sensitivity: With chronic use, MK-677 can worsen insulin sensitivity. This is clinically significant — fasting blood glucose and HbA1c should be monitored during extended use. This is the primary reason cycling is recommended.

Lethargy: Some users report feeling drowsy or tired, especially at higher doses. This can be managed by dosing before bed.

Tingling and numbness: Carpal tunnel-like symptoms in the hands, indicating elevated GH levels. May require dose reduction.

MK-677 should be avoided by anyone with diabetes or pre-diabetes due to its effects on insulin sensitivity. It should also be avoided by anyone with active cancer due to elevated IGF-1 levels.